参考文章(54)
G. DOLAN, ESOS: a European study on the orthopaedic status of patients with haemophilia and inhibitors. Haemophilia. ,vol. 11, pp. 24- 25 ,(2005) , 10.1111/J.1365-2516.2005.01158.X
Rolf C. R. Ljung, Elsy Sjörin, Origin of mutation in sporadic cases of haemophilia A British Journal of Haematology. ,vol. 106, pp. 870- 874 ,(1999) , 10.1046/J.1365-2141.1999.01631.X
G I Ingram, The history of haemophilia. Journal of Clinical Pathology. ,vol. 29, pp. 469- 479 ,(1976) , 10.1136/JCP.29.6.469
R. LJUNG, Paediatric care of the child with haemophilia Haemophilia. ,vol. 8, pp. 178- 182 ,(2002) , 10.1046/J.1365-2516.2002.00631.X
C. R. Rizza, R. J. D. Spooner, P. L. F. Giangrande, , Treatment of haemophilia in the United Kingdom 1981-1996. Haemophilia. ,vol. 7, pp. 349- 359 ,(2001) , 10.1046/J.1365-2516.2001.00521.X
G. C. WHITE, C. L. KEMPTON, A. GRIMSLEY, B. NIELSEN, H. R. ROBERTS, Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs? Journal of Thrombosis and Haemostasis. ,vol. 3, pp. 1676- 1681 ,(2005) , 10.1111/J.1538-7836.2005.01375.X
A. D. Shapiro, J. Korth-Bradley, M.-C. Poon, Use of pharmacokinetics in the coagulation factor treatment of patients with haemophilia. Haemophilia. ,vol. 11, pp. 571- 582 ,(2005) , 10.1111/J.1365-2516.2005.01149.X
J-M. R. Saint-Remy, S. Lacroix-Desmazes, J. Oldenburg, Inhibitors in haemophilia: pathophysiology Haemophilia. ,vol. 10, pp. 146- 151 ,(2004) , 10.1111/J.1365-2516.2004.01009.X
Deloris E. Koziol, David K. Henderson, Risk analysis and occupational exposure to HIV and HBV Current Opinion in Infectious Diseases. ,vol. 6, pp. 506- 510 ,(1993) , 10.1097/00001432-199308000-00003
Craig S. Kitchens, Dealing with acquired hemophilia Blood. ,vol. 103, pp. 4375- 4375 ,(2004) , 10.1182/BLOOD-2004-04-1356